High-dose B12 Slows Functional Decline in Early-stage ALS, Data Show - ALS News Today
6/17/2022 12:00:00 AM2 years 10 months ago
by Marta Figueiredo, PhD
by Marta Figueiredo, PhD
Ultrahigh-dose methylcobalamin effectively slowed functional decline in people with early-stage ALS, clinical trial data show.
Treatment with ultrahigh-dose methylcobalamin the physiologically active form of vitamin B12 effectively slowed functional decline in people with early-stage amyotrophic lateral sclerosis (ALS) and m… [+5134 chars]
full article...